SCHEMBL2771980

SCHEMBL2771980

CCOC(=O)Cc1c(C)c(S(=O)(=O)c2ccc3ccccc3c2)n2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.51
ALDH1A1 P00352 7/20 0.47
KMT2A Q03164 4/20 0.47
MEN1 O00255 2/20 0.47
MAPT P10636 2/20 0.41
KDM4E B2RXH2 3/20 0.40
GLA P06280 1/20 0.40
HPGD P15428 1/20 0.40
HIF1A Q16665 2/20 0.39
NOD2 Q9HC29 3/20 0.39
NOD1 Q9Y239 3/20 0.39
NPSR1 Q6W5P4 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
LARS1 Q9P2J5 1/20 0.38
MAPK1 P28482 2/20 0.37
POLB P06746 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2770435 0.87 ALDH1A1 (0.40) GAAALDH1A1KMT2AMEN1LARS1
SCHEMBL2770132 0.72 ABCB1 (0.44) GAAALDH1A1L3MBTL1
SCHEMBL2769682 0.71 L3MBTL1 (0.41) GAAALDH1A1MAPTKDM4EGLA
SCHEMBL2769434 0.71 PTGDR2 (0.41) KDM4E
SCHEMBL2774077 0.69 POLB (0.38) GAAALDH1A1KMT2AMEN1MAPT
SCHEMBL10420167 0.68 GAA (0.65) GAAALDH1A1KMT2AMEN1MAPT
SCHEMBL2769329 0.68 SMN1; SMN2 (0.42) GAAALDH1A1KMT2AMAPTKDM4E
SCHEMBL3566841 0.67 ALDH1A1 (0.44) GAAALDH1A1KMT2AMEN1KDM4E
SCHEMBL4636923 0.65 L3MBTL1 (0.51) GAAALDH1A1MAPTKDM4EGLA
SCHEMBL5797968 0.65 KMT2A (0.68) GAAALDH1A1KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910357-B1 INDOLI ZINE DERIVATIVES AND THEIR USE AS CRTH2 ANTAGONISTS ARGENTA DISCOVERY LTD (GB) 2010-04-14 EP disclosed
US-20090163534-A1 Indolizine Derivatives ARGENTA DISCOVERY LIMITED (GB) 2009-06-25 US disclosed
EP-1910357-A2 INDOLI ZINE DERIVATIVES AND THEIR USE AS CRTH2 ANTAGONISTS Argenta Discovery Limited (GB) 2008-04-16 EP disclosed
WO-2006136859-A2 INDOLI ZINE DERIVATIVES AND THEIR USE AS CRTH2 ANTAGONISTS ARGENTA DISCOVERY LIMITED (GB) 2006-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163534-A1 Indolizine Derivatives HRH4, HRH2, NR1H2 GAA 4797/4885ALDH1A1 3086/4885KMT2A 3518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.